BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11472046)

  • 1. The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions.
    Sampram ES; Lindblad B
    Eur J Vasc Endovasc Surg; 2001 Aug; 22(2):134-8. PubMed ID: 11472046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
    Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
    Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prevalence of APC-resistance in vascular patients and in a normal population cohort in Western Germany.
    Aleksic M; Jahn P; Heckenkamp J; Wielckens K; Brunkwall J
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):160-3. PubMed ID: 15996603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilia in cardiac surgery-patients with symptomatic factor V Leiden.
    Massoudy P; Thielmann M; Müller-Beissenhirtz H; Görlinger K; Dietrich W; Herget-Rosenthal S; Jakob H
    J Card Surg; 2009; 24(4):379-82. PubMed ID: 19040405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance in patients with peripheral vascular disease.
    Sampram ES; Lindblad B; Dahlbäck B
    J Vasc Surg; 1998 Oct; 28(4):624-9. PubMed ID: 9786256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
    Weger M; Renner W; Pinter O; Stanger O; Temmel W; Fellner P; Schmut O; Haas A
    Eye (Lond); 2003 Aug; 17(6):731-4. PubMed ID: 12928685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgery of abdominal aorta with horseshoe kidney].
    Lotina SL; Davidović LB; Kostić DM; Velimirović DV; Petrović PLj; Perisić-Savić MV; KovacevićN S
    Srp Arh Celok Lek; 1997; 125(1-2):36-44. PubMed ID: 17974353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
    Rehak M; Rehak J; Müller M; Faude S; Faude F; Siegemund A; Krcova V; Slavik L; Hasenclever D; Scholz M; Wiedemann P
    Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular surgery and smoking--a retrospective multivariant analysis].
    Karner-Hanusch J; Mittlböck M; Salat A; Pichl K; Polterauer P
    Wien Med Wochenschr; 1994; 144(22-23):561-5. PubMed ID: 7701842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C resistance in anterior ischaemic optic neuropathy.
    Nagy V; Facsko A; Takacs L; Balazs E; Berta A; Balogh I; Edes I; Czuriga I; Pfliegler G
    Acta Ophthalmol Scand; 2004 Apr; 82(2):140-3. PubMed ID: 15043529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutation in factor II and factor V gene in patients with peripheral arterial occlusive disease].
    Abukishe A; Brandt M; Hedderich J; Hirt S; Lentz S; Schäfer H; Walluscheck K; Cremer J; Bruhn HD
    Hamostaseologie; 2006 Aug; 26(3):197-200. PubMed ID: 16906235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.